We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bariatric Technique Increases Insulin Sensitivity

By HospiMedica staff writers
Posted on 10 Feb 2005
A study of two techniques used in weight-loss surgery shows that billopancreatic diversion can double insulin sensitivity in patients, compared to gastric bypass surgery.

Excessively overweight patients can have many medical problems, including insulin resistance and often type 2 diabetes. More...
Bariatric surgery for such patients leads to weight loss and improves insulin sensitivity. In the study, 18 nondiabetic patients with severe obesity and 20 lean subjects underwent metabolic studies, including the measurement of insulin activity. The obese patients then underwent either gastric bypass, which restricts food intake by making the stomach very small, or billopancreatic diversion, which shortens the small intestine and reduces fat absorption. Patients were followed at five to six months and again at 16-24 months after surgery.

"In the present study, the physiological difference between gastric bypass and billopancreatic diversion was exploited to highlight the link between lipid malabsorption and insulin action,” explained Alza Muscelli, M.D., of the State University of Campinas (Sao Paulo, Brazil). "However, the choice of the optimal therapeutic strategy in these patients depends on a risk/benefit algorithm to be assessed in each patient.”

The study was published in the January 2005 issue of The American Journal of Medicine. Other researchers from the Catholic University in Rome (Italy) and the University of Pisa (Italy) also participated in the study.




Related Links:
University of Campinas

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.